Product Information
ERYTHROMYCIN DR 250 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $1.9250 per EA under NDC 13668058601. Its NADAC has been published 257 times since Nov 3, 2021.
FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668058601
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA211975FDA Approved
7/26/2021
TE Code
AB
On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 250 MG TABLET has been published 257 times since Nov 3, 2021, and over the history we have for it it has declined 57.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9250 per EA |
|---|---|
| All-time high | $5.1930 (Feb 16, 2022) |
| All-time low | $1.6915 (Feb 18, 2026) |
| 52-week high | $2.4837 |
| 52-week low | $1.6915 |
| Median price | $3.0791 |
| Average price | $3.2928 |
| Largest weekly change | +41.1% (Mar 22, 2023) |
| Weeks tracked | 257 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ERYTHROMYCIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $1.9250 per EA (NDC 13668058601), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN DR 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has declined 57.7%. It has been tracked across 257 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG TABLET?
Since Nov 3, 2021, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $5.1930 (Feb 16, 2022), with a median of $3.0791 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN DR 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN DR 250 MG TABLET?
ERYTHROMYCIN DR 250 MG TABLET (NDC 13668058601) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.